Print this article
- 05/16/2017

Merck KGaA considers transferring its units into subsidiaries

Pharma Horizon

Germany’s Merck KGaA is considering shifting its chemicals, healthcare and biotech supplies operations into separate subsidiaries next year to better manage its diversified businesses.

Such moves are often seen as a prelude to possible changes in ownership, including separate stock market listings, but a company spokesman denied this is the intention.

The group, which has an heritage that goes back to 17th-century, is still 70 percent owned by the holding company of its founder’s descendants and has pursued a diversified business model to reduce the risk of the family being heavily invested in one area.


Source: Reuters